Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17).
作者信息
Roh Eun
机构信息
Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
出版信息
Diabetes Metab J. 2023 Mar;47(2):301-303. doi: 10.4093/dmj.2023.0051. Epub 2023 Mar 15.
Abstract
摘要
相似文献
1
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17).利用计算机断层扫描中的视觉肌肉质量图评估肌少症与非酒精性脂肪性肝病、严重程度及肝纤维化的相关性（《糖尿病与代谢杂志》2023年；47卷：104 - 17页）
Diabetes Metab J. 2023 Mar;47(2):301-303. doi: 10.4093/dmj.2023.0051. Epub 2023 Mar 15.
2
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17).利用计算机断层扫描中的视觉肌肉质量图评估肌少症与非酒精性脂肪性肝病、严重程度及肝纤维化的相关性（《糖尿病代谢杂志》2023年；47:104 - 17）
Diabetes Metab J. 2023 Mar;47(2):304-305. doi: 10.4093/dmj.2023.0058. Epub 2023 Mar 15.
3
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography.基于 CT 视觉肌肉质量图探讨肌肉减少症与非酒精性脂肪性肝病及其严重程度和肝纤维化的相关性
Diabetes Metab J. 2023 Jan;47(1):104-117. doi: 10.4093/dmj.2022.0081. Epub 2023 Jan 26.
4
Screening of nonalcoholic fatty liver disease in patients with coronary heart disease by transient elastography: proceed with caution.通过瞬时弹性成像技术对冠心病患者进行非酒精性脂肪性肝病筛查：需谨慎行事。
Wien Klin Wochenschr. 2015 Jan;127(1-2):75-6. doi: 10.1007/s00508-014-0621-6. Epub 2014 Oct 11.
5
Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.放射影像学在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的应用。
Clin Liver Dis. 2018 Feb;22(1):93-108. doi: 10.1016/j.cld.2017.08.005. Epub 2017 Oct 10.
6
Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.2 型糖尿病患者非酒精性脂肪肝肝脂肪含量和肝纤维化严重程度与心脏外脂肪体积呈正相关：一项前瞻性研究。
Eur Radiol. 2018 Apr;28(4):1345-1355. doi: 10.1007/s00330-017-5075-6. Epub 2017 Oct 20.
7
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. FibroScan 可识别患有非酒精性脂肪性肝病和心血管损伤的患者。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):517-519. doi: 10.1016/j.cgh.2018.11.011. Epub 2018 Dec 8.
8
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9).晚期肝纤维化与2型糖尿病和非酒精性脂肪性肝病患者的慢性肾脏病相关（《糖尿病代谢杂志》2022年；46:630 - 639）
Diabetes Metab J. 2022 Nov;46(6):956-957. doi: 10.4093/dmj.2022.0381. Epub 2022 Nov 24.
9
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9).2型糖尿病和非酒精性脂肪性肝病患者的晚期肝纤维化与慢性肾脏病相关（《糖尿病与代谢杂志》2022年；46:630 - 639）
Diabetes Metab J. 2022 Nov;46(6):953-955. doi: 10.4093/dmj.2022.0374. Epub 2022 Nov 24.
10
Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression.肌肉脂肪变性而非肌肉减少症使非酒精性脂肪性肝病患者易发生早期脂肪性肝炎和纤维化进展。
Clin Gastroenterol Hepatol. 2023 Feb;21(2):388-397.e10. doi: 10.1016/j.cgh.2022.01.020. Epub 2022 Jan 31.
本文引用的文献
1
Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography.基于 CT 视觉肌肉质量图探讨肌肉减少症与非酒精性脂肪性肝病及其严重程度和肝纤维化的相关性
Diabetes Metab J. 2023 Jan;47(1):104-117. doi: 10.4093/dmj.2022.0081. Epub 2023 Jan 26.
2
Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.非酒精性脂肪肝疾病对肌肉减少症风险的影响：一项全国多中心前瞻性研究。
Hepatol Int. 2022 Jun;16(3):545-554. doi: 10.1007/s12072-021-10258-8. Epub 2021 Nov 15.
3
Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD.不良的肌肉组成与非酒精性脂肪性肝病（NAFLD）患者的功能表现不佳和代谢合并症有关。
JHEP Rep. 2020 Oct 28;3(1):100197. doi: 10.1016/j.jhepr.2020.100197. eCollection 2021 Feb.
4
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病发生发展过程中的骨骼肌功能障碍
J Clin Transl Hepatol. 2020 Dec 28;8(4):414-423. doi: 10.14218/JCTH.2020.00065. Epub 2020 Oct 15.
5
Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.利用肌肉-肝脏相互作用治疗非酒精性脂肪性肝炎。
Front Endocrinol (Lausanne). 2020 Dec 23;11:592373. doi: 10.3389/fendo.2020.592373. eCollection 2020.
6
Health Consequences of Sarcopenic Obesity: A Narrative Review.肌少症性肥胖的健康后果：叙述性综述。
Front Endocrinol (Lausanne). 2020 May 21;11:332. doi: 10.3389/fendo.2020.00332. eCollection 2020.
7
Sarcopenia: revised European consensus on definition and diagnosis.肌少症：定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
8
Muscle Quality and Muscle Fat Infiltration in Relation to Incident Mobility Disability and Gait Speed Decline: the Age, Gene/Environment Susceptibility-Reykjavik Study.肌肉质量和肌肉脂肪浸润与新发行动障碍和步态速度下降的关系：年龄、基因/环境易感性-雷克雅未克研究
J Gerontol A Biol Sci Med Sci. 2015 Aug;70(8):1030-6. doi: 10.1093/gerona/glv016. Epub 2015 Mar 7.
9
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study.老年人骨骼肌与力量的衰减：健康ABC研究。
J Appl Physiol (1985). 2001 Jun;90(6):2157-65. doi: 10.1152/jappl.2001.90.6.2157.
10
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content.通过计算机断层扫描测定的骨骼肌衰减与骨骼肌脂质含量相关。
J Appl Physiol (1985). 2000 Jul;89(1):104-10. doi: 10.1152/jappl.2000.89.1.104.
Zotero 插件